Neoleukin Therapeutics - Delisted Stock
Neoleukin Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Neoleukin Therapeutics was actively traded. Please check the stock traded under the symbol NGNE.
Neoleukin Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Neoleukin Therapeutics market risk premium is the additional return an investor will receive from holding Neoleukin Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neoleukin Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Neoleukin Therapeutics' alpha and beta are two of the key measurements used to evaluate Neoleukin Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
Delisting Warning - NLTX
Neoleukin Therapeutics was delisted
| The entity Neoleukin Therapeutics with a symbol NLTX was delisted from NASDAQ Exchange. Please try Neurogene with a symbol NGNE from now on. Check all delisted instruments accross multiple markets. |
Neoleukin Therapeutics Corporate Directors
Neoleukin Therapeutics corporate directors refer to members of a Neoleukin Therapeutics board of directors. The board of directors generally takes responsibility for the Neoleukin Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Neoleukin Therapeutics' board members must vote for the resolution. The Neoleukin Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Sarah Noonberg | Director | Profile | |
| Cantey Boyd | Director | Profile | |
| Lewis Williams | Director | Profile | |
| Sean Nolan | Director | Profile |
Still Interested in Neoleukin Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |